Lumasiran, sold under the brand name Oxlumo, is a medication for the treatment of primary hyperoxaluria type 1 (PH1).
Lumasiran, sold under the brand name Oxlumo, is a medication for the treatment of primary hyperoxaluria type 1 (PH1).
The most common side effects include injection site reactions and abdominal pain.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).